SARS-CoV-2 variant detection and identification
Effective genomic surveillance of SARS-CoV-2 variants begins with the right tools
Place your order directly with the manufacturer.
Great product with high quality results
Used for qualitative detection of specific SARS-CoV-2 mutations
Easy to understand the instructions. SARS-CoV-2 Variant ValuPanel™ assays gives highly specific and quality results. Highly recommended
Review Date: 11 Sept 2021 | LGC Biosearch Technologies
Emerging SARS-CoV-2 variants will require global monitoring to ensure diagnostic tests, vaccines, and other antiviral therapies remain effective. As the virus’ mutations change its transmissibility and/or severity, public health control measures can stay ahead of the curve by analysing a subset of positive COVID-19 patient samples. These genomic surveillance programs include genotyping and sequencing the mutations, which can help characterise known variants and discover novel variants.
Product Overview
Links
Related Products
Request Quote for All Products
Products Model Information
SARS-CoV-2 Variant ValuPanel™ assays
LGC Biosearch TechnologiesSARS-CoV-2 Variant ValuPanel™ assays consist of separately delivered probes and primers that are designed for qualitative detection of specific SARS-CoV-2 mutations by genotyping using reverse transcription-polymerase chain reaction (RT-PCR).